Gut microbiome shows no clear link to cognitive impairments in Parkinson’s disease

FHS
April 9, 2024
3:07 am

Study investigates the gut microbiome’s role in Parkinson’s disease patients with mild cognitive impairments, revealing no distinct microbiome signatures associated with MCI in PD compared to cognitively normal PD patients or controls.

Philogen, Sun Pharma seek EMA approval for melanoma therapy

Intended to be administered intralesionally for four weeks, Nidlegy aims to enhance the immune response against neoplastic lesions. Credit: New Africa / Shutterstock. Philogen and

June 4, 2024

CDC Advisors Support Updated COVID Shots for All

The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 in favor of recommending updated, monovalent, XBB-targeting COVID-19 shots for everyone age 6

September 13, 2023

Opinion | The Trouble With Upcoding Extends Far Beyond Ethics

Devereaux is a retired board-certified family physician. After a long day in my primary care practice in rural southwest Virginia, I still had one more

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.